首页> 外文期刊>Neurology India >Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: Early experience
【24h】

Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: Early experience

机译:使用扩展的内镜鼻内经蝶窦入路手术治疗某些垂体大腺瘤:早期经验

获取原文
           

摘要

Background and Objectives: The endoscopic transsphenoidal approach is commonly used surgical approach for pituitary adenomas. However, adenomas with dumbbell configuration, pure suprasellar location, and fibrous consistency are difficult to remove by this approach. Recently, the extended endoscopic endonasal approach (EEEA) has been utilized to excise this subgroup of pituitary adenomas successfully. Materials and Methods: Between January 2009 and December 2011, 13 patients with pituitary macroadenomas were treated with EEEA. The tumor subgroups included: Dumbbell tumor configuration (4), pure suprasellar tumor location (2), and large suprasellar tumors with subfrontal extension (2). Five patients had fibrous/recurrent tumors and required addition of transtubercular-transplanum extension to the standard endoscopic endonasal exposure for radical resection. Results: The tumor removal was gross total in 8 (61.5%) patients, subtotal in 4 (30.7%), and partial in 1 (7.7%) patient. Clinical improvement was observed in almost all patients, immediate relief in headaches in 88% and normalization of vision in 90% of patients with pre-operative visual disturbances. Three patients with secreting adenomas, two with growth hormone-secreting adenomas and one with prolactin-secreting adenoma, had normalization of hormonal status. Three patients developed temporary diabetes insipidus two patients suffered transient ischemic attacks and one patient with a recurrent giant pituitary adenoma experienced a serious injury to the perforating artery. Four patients (30.7%) developed post-operative cerebrospinal rhinorrhea and two patients required surgical repair. Conclusions: Our early experience suggests that the EEEA offers a potentially viable treatment option in certain pituitary tumors which are difficult to remove by the standard endoscopic approaches. However, longer follow-up and larger series are needed to establish the efficacy of this approach.
机译:背景与目的:内镜经蝶窦入路是垂体腺瘤的常用外科手术方法。但是,采用这种方法很难去除具有哑铃状,纯上鞍骨位置和纤维稠度的腺瘤。近来,扩展的内窥镜鼻内入路(EEEA)已被成功地用于切除该垂体腺瘤亚组。材料和方法:在2009年1月至2011年12月之间,对13例垂体大腺瘤患者进行了EEEA治疗。肿瘤亚组包括:哑铃形肿瘤构型(4),单纯的鞍上肿瘤位置(2)和具有额额下延伸的大型鞍上肿瘤(2)。五名患者患有纤维性/复发性肿瘤,需要在标准的内窥镜鼻腔内暴露基础上再加上经肾小管穿刺延伸,以进行根治性切除。结果:肿瘤切除总计8例(61.5%),小计4例(30.7%),部分切除1例(7.7%)。在几乎所有患者中,观察到临床改善,术前视力障碍的患者中,头痛的立即缓解率为88%,视力恢复正常的率为90%。 3名分泌腺瘤的患者,2名分泌生长激素的腺瘤和1名泌乳素分泌的腺瘤的荷尔蒙状态恢复正常。 3例患上尿崩症患者暂时性尿崩,2例经历短暂性脑缺血发作,1例复发性垂体巨腺瘤复发性穿孔动脉严重受伤。术后有4例(30.7%)发生脑脊液鼻漏,其中2例需要手术修复。结论:我们的早期经验表明,EEEA为某些垂体肿瘤提供了潜在的可行治疗选择,而这些垂体肿瘤很难通过标准的内窥镜检查方法清除。但是,需要更长的随访和更大的研究范围来确定这种方法的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号